BusinessCempra Receives Complete Response Letter From FDA For Solithromycin NDAsBy Nasdaq OMXDec 29, 2016, 11:55 AM UTC
BusinessToyama Chemical (a Subsidiary of FUJIFILM Holdings Corporation) Begins Phase 3 Studies in Japan With Cempra’s SolithromycinBy Nasdaq OMXDec 5, 2016, 1:01 PM UTC
BusinessCempra Receives $10 Million Milestone Payment From Toyama Chemical (a Subsidiary of FUJIFILM Holdings Corporation) as Solithromycin Progresses to Phase 3 Studies in JapanBy Nasdaq OMXNov 1, 2016, 11:30 AM UTC
BusinessCempra Reports Third Quarter 2016 Financial Results and Provides Corporate UpdateBy Nasdaq OMXOct 27, 2016, 8:17 PM UTC
BusinessCempra Reports Third Quarter 2016 Financial Results and Provides Corporate UpdateBy Nasdaq OMXOct 27, 2016, 8:17 PM UTC
BusinessCempra Presents Analysis Showing Rates of Failure for Existing CABP Antibiotics From Claims Database at Academy of Managed Care Pharmacy MeetingBy Nasdaq OMXOct 4, 2016, 8:15 PM UTC
